The company's board, which met today, has approved the sale of US stores - a non-core business of the company, Natco Pharma said in a regulatory filing.
The stores are owned by Natco Pharma Inc, a wholly owned subsidiary of the company.
The company however did not disclose financial details as well as reasons for the sale of the assets.
Natco Pharma was incorporated in Hyderabad in the year 1981 with an initial investment of Rs 33 lakh.
With a modest beginning of operations as a single unit with 20 employees, Natco today has five manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in new drug development.
Natco stock closed Rs 399.20, up 1.69 per cent, on BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
